Novel therapeutic strategies to counter Pseudomonas aeruginosa infections. (Q37984505)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22339195%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

title

Novel therapeutic strategies to counter Pseudomonas aeruginosa infections (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22339195%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

main subject

Pseudomonas aeruginosa

0 references

author

Craig Winstanley

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22339195%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

Joanne L Fothergill

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22339195%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Chloe E James

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22339195%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

publication date

1 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22339195%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anti-infective Therapy

23 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22339195%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22339195%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

219-235

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22339195%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22339195%20AND%20SRC:MED&resulttype=core&format=json

Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen

23 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Common virulence factors for bacterial pathogenicity in plants and animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Epidemiology of bacterial meningitis in children in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Pseudomonas infections in patients with AIDS and AIDS-related complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Complicated urinary tract infections treated with extended-release ciprofloxacin with emphasis on Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

The pathogenesis of bacterial keratitis: studies with Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Persistent and aggressive bacteria in the lungs of cystic fibrosis children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

British Thoracic Society guideline for non-CF bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Development of resistance in Pseudomonas aeruginosa obtained from patients with cystic fibrosis at different times

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Inhibition of tobramycin diffusion by binding to alginate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Multidrug-resistance efflux pumps - not just for resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Trends in antimicrobial susceptibility in UK centres: the MYSTIC Programme (1997-2002).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Future antibiotics scenarios: is the tide starting to turn?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

A multidrug efflux pump inhibitor reduces fluoroquinolone resistance in Pseudomonas aeruginosa isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

MexAB-OprM- and MexXY-overproducing mutants are very prevalent among clinical strains of Pseudomonas aeruginosa with reduced susceptibility to ticarcillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Fitness of in vitro selected Pseudomonas aeruginosa nalB and nfxB multidrug resistant mutants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Cystic fibrosis pathogenesis and the role of biofilms in persistent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Pseudomonas aeruginosa biofilms in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Stratified growth in Pseudomonas aeruginosa biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Gene expression in Pseudomonas aeruginosa biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Bacterial Biofilms: An Emerging Link to Disease Pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Use of Pseudomonas biofilm susceptibilities to assign simulated antibiotic regimens for cystic fibrosis airway infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Randomized trial of biofilm testing to select antibiotics for cystic fibrosis airway infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Growth in glucose-based medium and exposure to subinhibitory concentrations of imipenem induce biofilm formation in a multidrug-resistant clinical isolate of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Ceftazidime, gentamicin, and rifampicin, in combination, kill biofilms of mucoid Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

The clinical impact of bacterial biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Pseudomonas aeruginosa biofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Roles of cyclic diguanylate in the regulation of bacterial pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Signals, regulatory networks, and materials that build and break bacterial biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Pseudomonas aeruginosa lectin LecB is located in the outer membrane and is involved in biofilm formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

The galactophilic lectin, LecA, contributes to biofilm development in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Inhibition and dispersion of Pseudomonas aeruginosa biofilms by glycopeptide dendrimers targeting the fucose-specific lectin LecB

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Inhalation with fucose and galactose for treatment of Pseudomonas aeruginosa in cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Successful treatment of Pseudomonas aeruginosa respiratory tract infection with a sugar solution--a case report on a lectin based therapeutic principle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Pseudomonas aeruginosa biofilms: role of the alginate exopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Role of exopolysaccharides in Pseudomonas aeruginosa biofilm formation and architecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Mathematical model of beta-lactam penetration into a biofilm of Pseudomonas aeruginosa while undergoing simultaneous inactivation by released beta-lactamases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Alginate lyase enhances antibiotic killing of mucoid Pseudomonas aeruginosa in biofilms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Genetically engineered alginate lyase-PEG conjugates exhibit enhanced catalytic function and reduced immunoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Analysis of Pseudomonas aeruginosa diguanylate cyclases and phosphodiesterases reveals a role for bis-(3'-5')-cyclic-GMP in virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

GGDEF and EAL domains inversely regulate cyclic di-GMP levels and transition from sessility to motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Riboswitches in eubacteria sense the second messenger cyclic di-GMP

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Monitoring of diguanylate cyclase activity and of cyclic-di-GMP biosynthesis by whole-cell assays suitable for high-throughput screening of biofilm inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Uracil influences quorum sensing and biofilm formation in Pseudomonas aeruginosa and fluorouracil is an antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Molecular mechanisms of compounds affecting bacterial biofilm formation and dispersal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Characterization of nutrient-induced dispersion in Pseudomonas aeruginosa PAO1 biofilm

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Characterization of starvation-induced dispersion in Pseudomonas putida biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Induction of rapid detachment in Shewanella oneidensis MR-1 biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Nitric oxide signaling in Pseudomonas aeruginosa biofilms mediates phosphodiesterase activity, decreased cyclic di-GMP levels, and enhanced dispersal

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

A fatty acid messenger is responsible for inducing dispersion in microbial biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Bacteriophage and phenotypic variation in Pseudomonas aeruginosa biofilm development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

The biofilm life cycle and virulence of Pseudomonas aeruginosa are dependent on a filamentous prophage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Susceptibility of Gram-positive and -negative bacteria to novel nitric oxide-releasing nanoparticle technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Paradigm shift in discovering next-generation anti-infective agents: targeting quorum sensing, c-di-GMP signaling and biofilm formation in bacteria with small molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

High-throughput screens for small-molecule inhibitors of Pseudomonas aeruginosa biofilm development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Impact of silver-containing wound dressings on bacterial biofilm viability and susceptibility to antibiotics during prolonged treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Road to clinical efficacy: challenges and novel strategies for antimicrobial peptide development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Predatory Bdellovibrio bacteria use gliding motility to scout for prey on surfaces.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Effects of orally administered Bdellovibrio bacteriovorus on the well-being and Salmonella colonization of young chicks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Predation of human pathogens by the predatory bacteria Micavibrio aeruginosavorus and Bdellovibrio bacteriovorus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Expression of Pseudomonas aeruginosa virulence genes requires cell-to-cell communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Central role of quorum sensing in regulating the production of pathogenicity factors in Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Functions required for extracellular quinolone signaling by Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Quorum sensing and virulence of Pseudomonas aeruginosa during lung infection of cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Identification, timing, and signal specificity of Pseudomonas aeruginosa quorum-controlled genes: a transcriptome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

P. aeruginosa Biofilms in CF Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

A new regulator linking quorum sensing and iron uptake in Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

The involvement of cell-to-cell signals in the development of a bacterial biofilm

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Garlic blocks quorum sensing and promotes rapid clearing of pulmonary Pseudomonas aeruginosa infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Regulation of the xcp secretion pathway by multiple quorum-sensing modulons in Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Multiple homologues of LuxR and LuxI control expression of virulence determinants and secondary metabolites through quorum sensing in Pseudomonas aeruginosa PAO1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

GeneChip expression analysis of the VqsR regulon of Pseudomonas aeruginosa TB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Revisiting quorum sensing: Discovery of additional chemical and biological functions for 3-oxo-N-acylhomoserine lactones

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Regulation of quorum sensing in Pseudomonas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Quorum sensing in staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Staphylococcus quorum sensing in biofilm formation and infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Regulation of bacterial virulence by two-component systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Two-component signal transduction proteins as potential drug targets in medically important fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Two-component signal transduction as potential drug targets in pathogenic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Protective anti-V antibodies inhibit Pseudomonas and Yersinia translocon assembly within host membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

In vivo-induced genes in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Siderophore-mediated signaling regulates virulence factor production in Pseudomonasaeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Identification of type II and type III pyoverdine receptors from Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

The pyocins of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Genetic analysis of a pyocin-resistant lipooligosaccharide (LOS) mutant of Haemophilus ducreyi: restoration of full-length LOS restores pyocin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Role of bacteriocins in mediating interactions of bacterial isolates taken from cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Retargeting R-type pyocins to generate novel bactericidal protein complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Antibacterial efficacy of R-type pyocins towards Pseudomonas aeruginosa in a murine peritonitis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Isolation and purification of enterocin E-760 with broad antimicrobial activity against gram-positive and gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Detection and characterization of the novel bacteriocin entomocin 9, and safety evaluation of its producer, Bacillus thuringiensis ssp. entomocidus HD9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

A predicted S-type pyocin shows a bactericidal activity against clinical Pseudomonas aeruginosa isolates through membrane damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Are bacteriocins underexploited? Novel applications for old antimicrobials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Bacteriocins to control Campylobacter spp. in poultry--A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Antimicrobial peptides and bacteriocins: alternatives to traditional antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Novel anti-microbial therapies for dental plaque-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Pyocin S2 (Sa) kills Pseudomonas aeruginosa strains via the FpvA type I ferripyoverdine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Evolutionary relationships among diverse bacteriophages and prophages: all the world's a phage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

21 January 2018

Bacteriophage Therapy

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Population and evolutionary dynamics of phage therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Bacteriophage therapy. Stalin's forgotten cure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

The use of phages for the removal of infectious biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Bacteriophages for the treatment of Pseudomonas aeruginosa infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Reduction in exopolysaccharide viscosity as an aid to bacteriophage penetration through Pseudomonas aeruginosa biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Structural changes induced by a lytic bacteriophage make ciprofloxacin effective against older biofilm of Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Characterization of JG024, a pseudomonas aeruginosa PB1-like broad host range phage under simulated infection conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Antibacterial efficacy of phages against Pseudomonas aeruginosa infections in mice and Drosophila melanogaster

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Bacteriophages can treat and prevent Pseudomonas aeruginosa lung infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa ; a preliminary report of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

In vitro lung delivery of bacteriophages KS4-M and ΦKZ using dry powder inhalers for treatment of Burkholderia cepacia complex and Pseudomonas aeruginosa infections in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

European regulatory conundrum of phage therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Dispersing biofilms with engineered enzymatic bacteriophage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Therapy of experimental pseudomonas infections with a nonreplicating genetically modified phage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Use of bacteriophage endolysin EL188 and outer membrane permeabilizers against Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Peptidoglycan lytic activity of the Pseudomonas aeruginosa phage phiKZ gp144 lytic transglycosylase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Bacteriophage lysins as effective antibacterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Vaccines and immunotherapy against Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Use of a Pseudomonas Aeruginosa vaccine in pateints with acute leukemia and cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Novel immunotherapeutic approaches to the treatment of infections caused by Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

An engineered human antibody fab fragment specific for Pseudomonas aeruginosa PcrV antigen has potent antibacterial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

PcrV immunization enhances survival of burned Pseudomonas aeruginosa-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

A novel host defense system of airways is defective in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Tackling antibiotic resistance: a dose of common antisense?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Sequencing technologies - the next generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Mining quorum sensing regulated proteins - Role of bacterial cell-to-cell communication in global gene regulation as assessed by proteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

How to discover new antibiotics: harvesting the parvome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Targeted anti bacterial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Pseudomonas Genome Database: facilitating user-friendly, comprehensive comparisons of microbial genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Use of subtractive hybridization to identify a diagnostic probe for a cystic fibrosis epidemic strain of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Fluctuations in phenotypes and genotypes within populations of Pseudomonas aeruginosa in the cystic fibrosis lung during pulmonary exacerbations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Microbial diversity in the sputum of a cystic fibrosis patient studied with 16S rDNA pyrosequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Moving pictures of the human microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

The airway microbiome in cystic fibrosis and implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

The role of bacteria in the pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Transcriptome analysis of quorum-sensing regulation and virulence factor expression in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Passive immunisation against Pseudomonas aeruginosa recombinant flagellin in an experimental model of burn wound sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

Silver against Pseudomonas aeruginosa biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.168

21 January 2018

Identifiers

DOI

10.1586/ERI.11.168

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22339195%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference